(Q34376919)

1 August 2017

title

Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

1 reference

3

Elisa Bruno

1 reference

1 August 2017

Marina Picillo

16

0 references

Alberto Albanese

object named as

Alberto Albanese

2

0 references

Alfredo Berardelli

10

object named as

Alfredo Berardelli

1 reference

1 August 2017

4

Carlo Colosimo

1 reference

1 August 2017

1

Mario Zappia

1 reference

1 August 2017

Graziella Quattrocchi

8

object named as

Graziella Quattrocchi

1 reference

1 August 2017

7

Alessandra Nicoletti

1 reference

1 August 2017

Graziella Filippini

5

1 reference

1 August 2017

Paolo Martinelli

6

1 reference

1 August 2017

Giovanni Abbruzzese

9

1 reference

1 August 2017

Roberta Allegra

11

1 reference

1 August 2017

Maria Stella Aniello

12

1 reference

1 August 2017

Antonio E Elia

13

1 reference

1 August 2017

Davide Martino

14

1 reference

1 August 2017

Daniela Murgia

15

1 reference

1 August 2017

Giovanna Squintani

17

1 reference

1 August 2017

publication date

11 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

260

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

714-740

1 reference

How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Clinical practice. Essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Essential tremor: a heterogenous disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Disability in essential tremor: effect of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Is essential tremor benign?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Treatment of patients with essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Diagnostic criteria for essential tremor: a population perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Assessing tremor severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Validation of a portable instrument for assessing tremor severity in epidemiologic field studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Metoprolol and propranolol in essential tremor: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Clinical response to long action propranolol in 40 patients diagnosed with essential tremor with no previous treatment: an open, non-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Comparison between the effects of pindolol and propranolol on essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

beta-Adrenoreceptor antagonists in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

The comparative effects of ICI 118551 and propranolol on essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Propranolol and propranolol-LA in essential tremor: a double blind comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Effects of zonisamide on isolated head tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Essential voice tremor: treatment with propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Propranolol treatment of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Relationship between plasma propranolol concentration and relief of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Randomized trial comparing primidone initiation schedules for treating essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Use of primidone in low doses (250 mg/day) versus high doses (750 mg/day) in the management of essential tremor. Double-blind comparative study with one-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Topiramate in essential tremor: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

The effect of levetiracetam on essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Efficacy of alprazolam for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Low doses of topiramate are effective in essential tremor: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

An open-label pilot study of levetiracetam for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Levetiracetam for the treatment of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Zonisamide for essential tremor: an evaluator-blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Benign familial tremor treated with primidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Primidone in essential tremor of the hands and head: a double blind controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Efficacy of primidone in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Quantitative comparison of barbiturates in essential hand and head tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Clinical and electromyographic assessment of essential tremor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Double-blind comparison of primidone and phenobarbital in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Olanzapine versus propranolol in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Olanzapine efficacy in the treatment of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Quetiapine and essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Botulinum toxin treatment for functional disability induced by essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Botulinum toxin treatment of tremors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Botulinum toxin A injections for the treatment of hand tremors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Long-term follow-up results of selective VIM-thalamotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Long-term results of stereotaxy in the treatment of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Thalamotomy for essential and cerebellar tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Lesion volume and clinical outcome in stereotactic pallidotomy and thalamotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Stereotactic thalamotomy in the treatment of essential tremor of the upper extremity: reassessment including a blinded measure of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

A model predicting optimal parameters for deep brain stimulation in essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Thalamic deep brain stimulation: effects on the nontarget limbs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Thalamic deep brain stimulation: comparison between unilateral and bilateral placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Effects of thalamic deep brain stimulation based on tremor type and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Deep brain stimulation for essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Multicentre European study of thalamic stimulation in parkinsonian and essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Impact of thalamic deep brain stimulation on disability and health-related quality of life in patients with essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Multicentre European study of thalamic stimulation in essential tremor: a six year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Effect of stimulation frequency on tremor suppression in essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Thalamic deep brain stimulation for management of essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Postural tremor suppression is dependent on thalamic stimulation frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Long-term evaluation of deep brain stimulation of the thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Factors involved in long-term efficacy of deep brain stimulation of the thalamus for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Long-term effect of deep brain stimulation for essential tremor on activities of daily living and health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Deep brain stimulation is preferable to thalamotomy for tremor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

On-demand deep brain stimulation for essential tremor: a report on four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Reduction in voice tremor under thalamic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Uniform qualitative electrophysiological changes in postoperative rest tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Clinical response to varying the stimulus parameters in deep brain stimulation for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Tremor response to polarity, voltage, pulsewidth and frequency of thalamic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Stimulation of the subthalamic region for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Effect of the beta adrenergic blocking agent propranolol on essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Effects of timolol and atenolol on benign essential tremor: placebo-controlled studies based on quantitative tremor recording

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Levetiracetam is not effective for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Double-blind controlled trial of gabapentin in essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6628-X

Criteria for the diagnosis of essential tremor

21 January 2018

1 reference

12 December 2020

Clozapine in the treatment of tremor.

1 reference

12 December 2020

Gamma Knife thalamotomy for essential tremor

1 reference

12 December 2020

Effect of alcohol on tremors: comparison with propranolol

1 reference

12 December 2020

Introduction. Essential tremor

1 reference

12 December 2020

Topiramate and essential tremor

1 reference

12 December 2020

Primidone and propranolol in essential tremor: a study based on quantitative tremor recording and plasma anticonvulsant levels

1 reference

12 December 2020

Nicardipine versus propranolol in essential tumor

1 reference

12 December 2020

Treatment of essential tremor with arotinolol

1 reference

12 December 2020

Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004*

1 reference

12 December 2020

Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor

1 reference

12 December 2020

Guidelines for allergic rhinitis need to be used in primary care

1 reference

12 December 2020

Double-blind controlled study of primidone in essential tremor: preliminary results.

1 reference

12 December 2020

Phenobarbitone in essential tremor

1 reference

12 December 2020

Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration

1 reference

12 December 2020

Surgical interventions in the treatment of Parkinson's disease (PD) and essential tremor (ET): medial pallidotomy in PD and chronic deep brain stimulation (DBS) in PD and ET.

1 reference

12 December 2020

Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up

1 reference

12 December 2020

Thalamic stimulation for the treatment of midline tremors in essential tremor patients

1 reference

12 December 2020

A double-blind trial of clonazepam in benign essential tremor

1 reference

12 December 2020

Zonisamide in patients with essential tremor and Parkinson's disease

1 reference

12 December 2020

Stereotactic ventral intermedial thalamotomy for the treatment of essential tremor: results of a series of 37 patients

1 reference

12 December 2020

Clonidine versus propranolol in the treatment of essential tremor. A double-blind trial with a one-year follow-up

1 reference

12 December 2020

Gamma knife thalamotomy for treatment of tremor: long-term results

1 reference

12 December 2020

Essential tremor: Treatment with propranolol

1 reference

12 December 2020

Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysis.

1 reference

12 December 2020

Zonisamide for essential tremor

1 reference

12 December 2020

Long-term therapy of essential tremor with propranolol

1 reference

12 December 2020

Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias

1 reference

12 December 2020

Comparative studies on the effects of beta-adrenergic blockers in essential tremor

1 reference

12 December 2020

Propranolol therapy for essential tremor of the head

1 reference

12 December 2020

Effectiveness and safety of levetiracetam in patients with essential tremor: data from an open 11-week follow-up trial

1 reference

12 December 2020

Understanding essential tremor. Differential diagnosis and options for treatment

1 reference

12 December 2020

Treatment of essential tremor with propranolol

1 reference

12 December 2020

Nadolol in essential tremor

1 reference

12 December 2020

Postural tremor of Parkinson's disease

1 reference

12 December 2020

Phenobarbital and propranolol in essential tremor: A double-blind controlled clinical trial

1 reference

12 December 2020

Botulinum toxin injections for essential voice tremor

1 reference

12 December 2020

Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression

1 reference

12 December 2020

Beta-blockers in essential tremor

1 reference

12 December 2020

Gabapentin in the treatment of tremor

1 reference

12 December 2020

beta-Adrenoceptor antagonists and essential tremor

1 reference

12 December 2020

A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor

1 reference

12 December 2020

1 reference

12 December 2020

Agreement among movement disorder specialists on the clinical diagnosis of essential tremor

1 reference

12 December 2020

Subthalamic stimulation for essential tremor. Short- and long-term results and critical target area

1 reference

12 December 2020

Acute and chronic effects of propranolol and primidone in essential tremor

1 reference

12 December 2020

1 reference

12 December 2020

Bilateral thalamic stimulation for the treatment of essential tremor

1 reference

12 December 2020

Botulinum toxin treatment of essential head tremor

1 reference

12 December 2020

Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis.

1 reference

12 December 2020

Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee.

1 reference

12 December 2020

The effect of the GABA-agonist, progabide, on benign essential tremor. A controlled clinical trial

1 reference

12 December 2020

Clinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremor

1 reference

12 December 2020

Users' Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group

1 reference

12 December 2020

New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide

1 reference

12 December 2020

Thalamic lesions produced by gamma thalamotomy for movement disorders

1 reference

12 December 2020

Acute and chronic effects of clozapine in essential tremor

1 reference

12 December 2020

Amantadine in essential tremor

1 reference

12 December 2020

Amplitude of benign essential tremor and response to propranolol

1 reference

12 December 2020

Long-acting propranolol in essential tremor

1 reference

12 December 2020

Kinetic predominant essential tremor: successful treatment with clonazepam

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor

1 reference

12 December 2020

Pharmacologic probe with progabide of GABA mechanisms in essential tremor

1 reference

12 December 2020

The Washington Heights-Inwood Genetic Study of Essential Tremor: Methodologic Issues in Essential-Tremor Research

1 reference

12 December 2020

Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremor

1 reference

12 December 2020

Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00415-012-6628-X

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1046106394

0 references

1 reference